Wockhardt
Healthcare
Somerset bets on CDMO firm in fifth deal from second fund
Somerset Indus Capital Partners, a healthcare-focused private equity firm, has closed its fifth investment from its second fund with a ......
Finance
India Inc's legal costs slip off FY19 perch; Sun Pharma retakes top spot
India Inc’s legal expenses pace came down to a high single digit rate in 2019-20 from the fastest growth seen ......
Healthcare
Wockhardt's Huzaifa Khorakiwala to launch healthcare-focused angel fund
Huzaifa Khorakiwala, executive director at drugmaker Wockhardt, is set to float a healthcare-focused angel fund that puts him among a ......
Healthcare
USFDA bans import of drugs from Wockhardt's Ankleshwar plant
In yet another blow to drug maker Wockhardt, US Food and Drug Administration (USFDA) has banned import of products manufactured ......
Healthcare
Wockhardt raises $13.4M through IPO of European arm
Mumbai-based generic drugmaker Wockhardt Ltd has raised CHF 11.86 million ($13.37 million) in an initial public offering (IPO) through its ......
Healthcare
Wockhardt gets warning from USFDA over Chikalthana plant at Aurangabad
In another setback to Mumbai-based generic drugmaker Wockhardt Ltd, it has received an import alert from US Food and Drug ......
Healthcare
Wockhardt gets notice from UK regulator for its Daman plant
UK’s drug regulator has revoked the quality compliance certificate of Mumbai-based Wockhardt Ltd’s factory located in Nani Daman, making it ......
Healthcare
Wockhardt says FDA alert affects potential sales of $100M
Drug maker Wockhardt Ltd said up to $100 million in annualised revenue could be lost as a result of a ......